• Citer

Prediction of response to Gefitinib in NSCLC by EGFR protein expression is increased by a novel antibody and the use of AQUA technology.

par Reyna Asuncion, B.;Yoshida, K.;Ranger-Moore, J.;Zhao, Jamie;Wynes, Murry W;Mascaux, Céline ;Powell, William ;Ikeda, N.;Hirsch, Fred R;Kato, Yasufumi
Référence Chicago Multidisciplinary Symposium in Thoracic Oncology (December 2010: Chicago, USA)
Publication Non publié, 2010

Communication à un colloque

• Détails

Titre:	Prediction of response to Gefitinib in NSCLC by EGFR protein expression is increased by a novel antibody and the use of AQUA technology.
Auteur:	Reyna Asuncion, B.; Yoshida, K.; Ranger-Moore, J.; Zhao, Jamie; Wynes, Murry W; Mascaux, Céline; Powell, William; Ikeda, N.; Hirsch, Fred R; Kato, Yasufumi
Informations sur la publication:	Chicago Multidisciplinary Symposium in Thoracic Oncology (December 2010: Chicago, USA)
Statut de publication:	Non publié, 2010
Sujet CREF:	Sciences bio-médicales et agricoles
Note générale:	S504, abstract 10
Langue:	Anglais